![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Unexpected Compound Levels Incite J&J Tylenol Recall
Unexpected Compound Levels Incite J&J Tylenol Recall
August 26, 2011
Johnson & Johnson (J&J) subsidiary McNeil Consumer Healthcare is again recalling Tylenol products, this time for higher-than-expected levels of a compound.
Washington Drug Letter
Washington Drug Letter
Upcoming Events
-
21Oct